Form 4: Director Patrick J. Healy Reports Medline Stock Transfer
Statement of Changes in Beneficial Ownership
Director Patrick J. Healy reported a distribution in kind of Medline Inc. Class A common stock resulting in increased direct and indirect holdings.
Summary
- Director Patrick J. Healy acquired 179,762 shares of Class A Common Stock directly.
- An additional 22,344 shares were acquired indirectly through a family trust.
- The transactions were executed on May 28, 2026, as a distribution in kind from investment entities.
- Following these transactions, the reporting person holds 1,387,921 shares directly and 172,383 shares indirectly via a family trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine change in beneficial ownership structure rather than a strategic or operational shift.
Positives
- Increased direct ownership stake by the director signals alignment with company equity.
- The transaction represents a distribution in kind rather than a market sale, indicating no immediate liquidation of holdings.
Negatives
- None identified; this is a routine ownership change filing.
Risks
- None identified; this is a routine ownership change filing.
Future Outlook
No forward-looking guidance or operational outlook provided in this filing.
Industry Context
StockSavvy.ai notes that this filing reflects internal restructuring of equity holdings by a director associated with a private equity firm, which is common practice following fund distributions and does not necessarily reflect a change in the company's operational outlook.
Comparison to Industry Standards
- The filing follows standard SEC reporting requirements for Section 16 insiders.
- Distribution in kind transactions are standard practice for private equity partners managing fund exits or distributions.
Related Party Transactions
- The transaction involves a distribution from Hellman & Friedman Capital Partners X (Parallel), L.P. and HFCP X (Parallel A), L.P. to the reporting person.
Stakeholder Impact
- Minimal impact on external stakeholders as this is a change in the form of ownership rather than a change in total outstanding shares or market supply.
Next Steps
- None
Key Dates
| Date | Description |
|---|---|
| 05/28/2026 | Date of the earliest transaction reported. |
| 06/01/2026 | Date of the filing signature. |
Keywords
Medline, MDLN, Form 4, Insider Trading, Director Ownership, Equity Distribution
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.